Undiagnosed Tumor/Undifferentiated Mass Registry

Overview

About this study

The purpose of this study is to create a research registry to prospectively collect research biospecimens and corresponding clinical data from subjects with an undiagnosed tumor or undifferentiated mass.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:  

  • Patient presenting to a General Internal Medicine Service.
  • Patient in one of the 3 Mayo Clinic Campuses (Rochester, Arizona, Florida).
  • Patient with an undiagnosed mass: New or enlarging lymph nodes clinically or on imaging:
    • New mass on imaging of soft tissues, bone, spleen, adrenal gland, retroperitoneum, or intraabdominal location without clear organ association.
  • Patient has understood and signed the informed consent to participate in the registry.
  • Patient has the ability to complete all aspects of registry enrollment.
  • Aged 18 and older.

 Exclusion Criteria:   

  • Mass involving the breast, brain, kidney, lung, ovary/adnexa, liver, pancreas, sinus, throat, or thyroid gland will be addressed by the respective specialty areas.  
  • Patients with a known history of any condition or factor judged by the investigator to preclude participation in the registry or which might hinder adherence.
  • Lacking the capacity to consent.
  • Prisoners or institutionalized individuals.
  • Pregnant women.

Eligibility last updated 9/17/21. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Gilman, M.D., MSM

Open for enrollment

Contact information:

Department of Medicine (DOM) Research Hub

(507) 266-1944

DOMRESEARCHHUB@mayo.edu

Jacksonville, Fla.

Mayo Clinic principal investigator

Nancy Dawson, M.D.

Open for enrollment

Contact information:

Nancy Dawson M.D.

(904) 956-3032

Dawson.Nancy11@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Steven Ressler, M.D.

Open for enrollment

Contact information:

Bianca Montelongo

(480) 301-4665

Montelongo.Bianca@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions